Redgumme,
Is this what you are referring to:
Announcement, date 12 May, 2003:
"Our strategy has always been to continue to build commercial value for PI-88 by providing additional clinical data to optimize value outcomes, with parallel screening of potential licensing partners for the late stage development, registration approval and marketing of PI-88".
Gerry